Company / Operating Income per Share
RHYTHM PHARMACEUTICALS, INC. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$3.08
FY2025
5-year range
-$4.47 / -$3.08
FY2021-FY2025
Trend
+31.1%
vs FY2024
Sector context
#141 of 201
Health Care
What the data says
At $-3.08, RHYTHM PHARMACEUTICALS, INC.'s operating income per share ranks #141 of 201 in the Health Care sector. Operating Income per Share has fluctuated over the past 10 years, ranging from $-4.47 in FY2024 to $-2.54 in FY2016.
Based on SEC 10-K filings.
-3.08 in FY2025.
Improved from $-3.26 to $-3.08 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#141 of 201 in Health CareTop 70% of 201This company -$3.08 Sector average -$28.56
▼
+89.2% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 31.1% year-over-year.
- Ranks #141 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2016.
- Lowest operating income per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -2.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.08 | +31.1% |
| FY2024 | -$4.47 | -37.2% |
| FY2023 | -$3.26 | +5.3% |
| FY2022 | -$3.44 | -0.3% |
| FY2021 | -$3.43 | -10.8% |
| FY2020 | -$3.10 | +22.8% |
| FY2019 | -$4.01 | -39.5% |
| FY2018 | -$2.87 | +9.6% |
| FY2017 | -$3.18 | -25.1% |
| FY2016 | -$2.54 | -145.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026